Has Mary Poonen received payments from drug or device companies?

Yes. Drug and device makers reported $11,304 in general payments to Mary Poonen across 203 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mary Poonen did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mary Poonen come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mary Poonen

Psychiatry · Huntington Beach, CANPI 1780675256

Payments from drug & device makers

$11,304in general payments, 2019–2025

Across 203 payments — averaging $55.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$3K
Johnson & Johnson$2K
Sunovion Pharmaceuticals Inc.$2K
AbbVie$1K
Teva Pharmaceuticals USA, Inc.$949
Neurocrine Biosciences, Inc.$779
plus $2K from 8 others

What the payments were for

Travel & lodging$220%
Food & beverage$11,282100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	59	$2,924
Johnson & Johnson	37	$2,244
Sunovion Pharmaceuticals Inc.	31	$1,702
AbbVie(2 entities)	17	$1,158
Teva Pharmaceuticals USA, Inc.	19	$949
Neurocrine Biosciences, Inc.	10	$779
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$371
Otsuka America Pharmaceutical, Inc.	8	$336
Indivior Inc.	3	$240
E.r. Squibb & Sons, L.L.C.	5	$228
Ironshore Pharmaceuticals Inc.	2	$152
Janssen Scientific Affairs, LLC	2	$144
OWP Pharmaceuticals, Inc.	2	$46
Sumitomo Pharma America, Inc.	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARISTADA$4,389
LYBALVI$3,296
INVEGA SUSTENNA$1,437
ARISTADA INITIO$1,097
LATUDA$1,092
VRAYLAR$897
INGREZZA$684
INVEGA TRINZA$572
UZEDY$332
CAPLYTA$250
ABILIFY MAINTENA$241
Austedo XR$236
SPRAVATO$221
Jornay PM 20mg capsules (Bottle of 100)$141
PERSERIS$121
COBENFY$119

How this compares

$11,304 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Abilify MaintenaAripiprazole	16	$45,472
Aripiprazole	37	$1,810
Chlorpromazine Hcl	13	$1,639
Olanzapine	60	$1,409
Haloperidol	24	$930
Lurasidone Hcl	14	$916
Mirtazapine	49	$404
Prazosin Hcl	35	$336
Buspirone Hcl	31	$252
Trazodone Hcl	12	$233
Fluoxetine Hcl	15	$144
Risperidone	34	$126
Escitalopram Oxalate	16	$118
Hydroxyzine Pamoate	27	$101
Sertraline Hcl	24	$71

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena	$336	$45,47216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Huntington Beach

Steven MacinaHuntington Beach$11.1M
Elly LeeIrvine$49.8M
Daniel ChuehOrange$17.9M
Eric ChavezSan Diego$15.5M
Lara ShirikjianTorrance$12.6M
John DuffySanta Ana$12M
Marina BusselPlaya Vista$12M
Sherry SoefjeOceanside$11.9M
Wakelin McNeelRosemead$11M
Donald AndersonBanning$10.5M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →